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Abstract
For a quantitative understanding of the process of adaptation, we need to understand its ‘‘raw material,’’ that is, the
frequency and fitness effects of beneficial mutations. At present, most empirical evidence suggests an exponential
distribution of fitness effects of beneficial mutations, as predicted for Gumbel-domain distributions by extreme value
theory. Here, we study the distribution of mutation effects on cefotaxime (Ctx) resistance and fitness of 48 unique beneficial
mutations in the bacterial enzyme TEM-1 b-lactamase, which were obtained by screening the products of random
mutagenesis for increased Ctx resistance. Our contributions are threefold. First, based on the frequency of unique mutations
among more than 300 sequenced isolates and correcting for mutation bias, we conservatively estimate that the total
number of first-step mutations that increase Ctx resistance in this enzyme is 87 [95% CI 75–189], or 3.4% of all 2,583 possible
base-pair substitutions. Of the 48 mutations, 10 are synonymous and the majority of the 38 non-synonymous mutations
occur in the pocket surrounding the catalytic site. Second, we estimate the effects of the mutations on Ctx resistance by
determining survival at various Ctx concentrations, and we derive their fitness effects by modeling reproduction and
survival as a branching process. Third, we find that the distribution of both measures follows a Fre´chet-type distribution
characterized by a broad tail of a few exceptionally fit mutants. Such distributions have fundamental evolutionary
implications, including an increased predictability of evolution, and may provide a partial explanation for recent
observations of striking parallel evolution of antibiotic resistance.
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Introduction
Adaptation of asexual organisms to their environment is driven
by the successive fixation of mutations that increase fitness. The
effect-size of beneficial mutations varies and the distribution of
beneficial fitness effects (DBFE) influences dynamics, outcome and
repeatability of adaptation [1–5]. Nevertheless, we know little
about the relative number and fitness effects of beneficial
mutations for two main reasons. First, beneficial mutations are
relatively scarce, which complicates empirical studies, because
large numbers of beneficial mutations are required to accurately
estimate the DBFE. Second, we lack a general theoretical basis for
understanding DBFEs [6,7]. Extreme value theory (EVT) provides
predictions for adaptation to small environmental changes. Under
these circumstances, the wild type has a relatively high fitness and
beneficial mutations are then drawn from the tail of the
distribution. Many commonly encountered parent distributions
(including normal, gamma, exponential and logistic distribution)
belong to the Gumbel domain. The tails of these distributions are
all exponential, comprising many mutations of small effect and few
of large effect [6–8]. Models that incorporate the effects of
beneficial mutations therefore often assume this distribution to be
exponential [3,6]. The prediction of an exponential DBFE has
been confirmed empirically using genotypes with high fitness [9–
11], although one study has found a gamma distribution [12]. For
low-fitness genotypes we lack a quantitative prediction, as often
EVT can no longer be applied. The DBFE appears no longer
exponential under these conditions and has been described by
distributions which are approximately normal [10,13].
Besides the Gumbel domain, two other domains of attraction
exist which encompass classes of distributions with truncated tails
(Weibull domain) and with heavy tails that decay as a power law
(Fre´chet domain) [7,14]. Note that the differences between the
three domains involve differences in the shape of the distribution
and do not imply differences in absolute selection coefficients.
While deviations from the Gumbel domain have been considered
as biologically less likely [7], there is no fundamental reason why
they may not occur [14], and it is therefore questionable whether
the DBFE can be described by a general (exponential) shape. Two
studies have already observed distributions with truncated tails
[15,16], but no support is known to us for Fre´chet-type
distributions. On average, adaptive walks to local fitness maxima
are longer in the Weibull than in the Gumbel domain [17–19],
while the likelihood for parallel evolution is reduced [14,20]. In the
Fre´chet domain, the probability that the fittest alleles are fixed is
enhanced, which brings the adaptive process close to the ‘‘greedy’’
limit [17,18,21] and increases the repeatability of adaptation
[14,18]. In addition, a heavy-tailed distribution reduces the
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fixation time of beneficial mutations, thereby mitigating the effects
of competition among beneficial mutations (clonal interference)
and reducing the opportunity for competition among clones
carrying multiple mutations [3,22,23].
We study the number and properties of adaptive mutations in a
single protein. So far, empirical studies of the DBFE were either
based on relatively small sets of characterized mutations [9–12,16]
or large sets of uncharacterized mutations [13,24]. We use TEM
b-lactamase as a model system and study the effects of unique
beneficial mutations for adaptation to cefotaxime (Ctx). Whereas
the original TEM-1 enzyme hydrolyzes several b-lactam antibi-
otics effectively, it has promiscuous (i.e. low) activity towards Ctx.
Several studies have shown that mutants with increased resistance
to Ctx are found in nature [25] or can be selected by using
iterative rounds of random mutagenesis and artificial selection
[2,26,27]. These studies already identified several beneficial
mutations and highly resistant mutants with multiple mutations,
but none have characterized the full adaptive potential or the
shape of the DBFE.
We use PCR mutagenesis to introduce random mutations into
TEM-1 and select beneficial mutations at low Ctx concentrations.
This way, we identify 48 unique beneficial mutations within a set
of 864 selected isolates. The total number of possible beneficial
mutations will be higher, and we estimate that at least 3.4% of all
2,583 possible base-pair mutations in the coding region of TEM-1
are beneficial. For each mutant, we measure Ctx resistance and
infer its fitness at various Ctx concentrations by modeling survival
and reproduction as a branching process. The distribution of
resistance phenotypes belongs to the Fre´chet domain and is
characterized by a large number of small-effect mutants and a few
exceptionally fit mutants. The DBFE is dependent on the fitness of
the wild type, and when wild-type fitness is low (at higher
antibiotic concentrations) the DBFE also belongs to the Fre´chet
domain.
Results
Estimating the total number of beneficial mutants
Escherichia coli cells that harbor plasmid-borne TEM-1 have
promiscuous activity towards Ctx. We introduced random
mutations into TEM-1 by PCR mutagenesis and selected resistant
bacteria at the lowest Ctx concentration (0.04 mg/mL) that
showed differentiation in survival between wild-type and mutant
libraries to minimize isolation bias against small-effect mutations
(Figure 1A). In total, 864 isolates - 72 isolates for each of the 12
independent PCRs - were collected. As a first screen of the
variation in Ctx resistance we determined the minimal inhibitory
Ctx concentration (MIC) for each isolate. MIC values of the
isolates ranged from 0.08 to more than 2.56 mg/mL, partly
showing overlap with the MIC of the wild type (Figure S1). The
distribution of MIC values is affected by the presence of isolates
with the TEM-1 allele (which have reduced, but positive survival
probability at 0.04 mg Ctx/mL), by spontaneous resistance
mutations in the bacterial chromosome, by alleles containing
multiple mutations and by the mutational bias of the DNA
polymerase used for mutagenesis (Table S1). To avoid all these
possible sources of bias, we focus on unique TEM mutants to
determine the DBFE.
We used the collection of 864 isolates to estimate the total
number of beneficial base-pair substitutions in three steps. First,
we sequenced the TEM alleles of 310 isolates, while balancing the
effort across the six MIC categories (Table S2). Second, we found
52 unique single mutants and determined which had a significant
benefit by estimating their effect on Ctx resistance after transfer of
the mutant allele to a naı¨ve vector and host (i.e. taken from
untreated frozen stocks). A sensitive continuous measure of Ctx
resistance was obtained by estimating the Ctx concentration where
a fraction 1024 of the cells produce a visible colony, called the
Inhibitory Concentration killing 99.99% (IC99.99, Figure S2).
Using two-tailed t-tests and serial-Bonferroni correction, we found
that the benefit of each of the 48 mutants with an IC99.99 higher
than that of TEM-1 was significant (Table S2). Third, we tried to
estimate the total number of beneficial mutations. Based on the
number of unique beneficial mutations relative to the number of
sequenced isolates in each MIC category, one can generate a
maximum likelihood (ML) estimate of the total number of
beneficial mutations per MIC category together with a 95%
confidence interval (Table 1; see Material and Methods). When
also taking the observed mutational bias of the polymerase into
account (Table S1), a total of at least 87 beneficial mutations (95%
CI 75–189) are estimated to exist. The ML estimates suggest that
the highest MIC categories (1.28 and $2.56) have been sampled
exhaustively, while our record is incomplete for the lowest MIC
categories. Correcting for missing mutations therefore shifts the
distribution of MIC values towards small-effect mutations
(Figure 1B). Note that the applied procedure yields a conservative
estimate of the total number of beneficial mutations due to possible
variation in observation probabilities among mutants (see Material
and Methods).
Characteristics of the mutations
The 48 identified beneficial mutations were located at 32 of the
291 amino acid positions (Figure 2A). The TEM polypeptide is
composed of a signal peptide and a mature protein. The majority
of the mutations (n= 41) were located in the mature protein, while
seven mutations were located in the signal peptide. Remarkably,
10 of the 48 mutations are synonymous mutations. Mutations in
the mature protein (average IC99.99 = 0.160 mg Ctx/mL) had a
significantly larger effect on resistance than those in the signal
peptide (IC99.99 = 0.078 mg Ctx/mL; two-sample t= 3.520,
df = 46, two-tailed P= 0.0010), and non-synonymous mutations
(IC99.99 = 0.166 mg Ctx/mL) had a significantly larger effect than
synonymous mutations (IC99.99 = 0.081 mg Ctx/mL; t= 3.238,
df = 46, two-tailed P= 0.0022). Several codons gave rise to
Author Summary
Although mutations with positive effect on fitness are rare,
they contribute disproportionally to evolution, because
they are favored by natural selection. Because they are rare
and hard to study experimentally, little is known about the
frequency and variation in fitness effects of beneficial
mutations, and it is often assumed that their effects follow
an exponential distribution. We quantified the total
number of beneficial mutations and their effects on
resistance for an enzyme that is the main target of
resistance against the antibiotic cefotaxime. Based on 48
unique beneficial mutations identified among more than
300 sequenced mutants, we estimate that at least 87 of the
2,583 possible point mutations (3.4%) in this enzyme are
beneficial. We measured survival of these mutants on a
range of antibiotic concentrations and derived estimates
of resistance and fitness. The recovered distribution
deviates from an exponential distribution due to the
presence of a few mutants with a very large effect. The
existence of such mutations will increase the predictability
of adaptation and shorten the length of adaptive
pathways.
Fitness Effects of Beneficial Mutations
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multiple beneficial mutations. Particularly the codons E104, G238,
E240, and R241 stood out, where three-four of the five-six
accessible amino acid replacements increased Ctx resistance. The
average resistance improvement per codon depended positively on
the number of adaptive mutations observed per codon
(F1,46 = 26.968, P,0.001).
The clustering of mutations becomes even more evident from
their position in the tertiary structure of the mature protein
(Figure 2B). The catalytic serine residue (S70) is positioned
between a domain consisting of five b-sheets packed against three
a-helices and a domain that consists of eight a-helices. Except for
E197V and A227T, all amino acid replacements are located in the
oxyanion pocket, which surrounds the catalytic site, or on loops
near the entrance of this pocket. The majority of the mutations are
located in the V-loop and the hinge between the b-sheets S3 and
S4, which are located directly opposite to each other and harbor
10 and 13 mutations, respectively. Eighteen of the non-synony-
mous mutations have to our knowledge never been identified,
whereas twenty were previously encountered in clinical isolates or
directed evolution experiments (Table S2; reviewed in [25]). The
set of new mutations includes mainly small-effect mutations, but
includes also R241P, which ranks third in terms of effect size.
Three of the 10 synonymous mutations have been found before in
clinical isolates (Table S2).
Distribution of resistance effects
The 48 beneficial mutants showed substantial variation in Ctx
resistance (IC99.99). Resistance ranged from 0.055 to 1.410 mg
Ctx/mL, where TEM-1’s resistance is 0.052 [SD = 0.0010] mg
Ctx/mL. However, TEM-1’s resistance is still significantly higher
than that of bacteria carrying the same plasmid without TEM-1
(IC99.99 = 0.033 [SD = 0.0034] mg Ctx/mL; two-sample
t= 8.627, df = 7, two-tailed P,0.0001), indicating that deleterious
mutations are possible as well.
To determine the shape of the distribution of resistance effects
of beneficial mutations (Figure 3A), we fitted the data to a
generalized Pareto distribution (GPD). The GPD is a right-skewed
distribution, parameterized with a scale parameter t and a shape
parameter k, that can model tails of a wide variety of distributions.
The shape parameter determines whether the tail distribution
belongs to the domain of distributions with exponential tails (k= 0;
Gumbel domain), truncated tails (k,0; Weibull domain) or heavy
tails that decay as a power law (k.0; Fre´chet domain). Our
estimates of k (ke) are typically between 0.5 and 1 (Figure 3B),
indicating that the distribution belongs to the Fre´chet domain.
EVT can only be applied when the observed values are drawn
from the tail of the distribution. This can be verified by gradually
removing mutations at the left side of the tail; when ke does not
change during this procedure this is evidence that the DBFE
corresponds to the tail of some distribution. The estimate ke is
roughly constant when considering the fittest 48 to 20 mutations
(Figure 3B and 3C), and becomes unstable beyond this point due
to the small number of data points. A likelihood-ratio test shows
that ke differs from the Gumbel domain hypothesis (k=0) with
more than 95% confidence for n.15 (Figure 3C).
We checked whether the results are robust with regard to the
criterion used to calculate resistance levels and depended on the
presence of specific mutations. Using the same analysis for the Ctx
concentration where a fraction 1022, 1023 and 1025 of the cells
survive, we confirmed that ke was in the Fre´chet domain
irrespective of which fraction was used to calculate resistance
levels (Figure S3). The ML estimator for the GPD is known to be
sensitive to individual mutations with exceptionally high resistance
levels [28]. In our dataset, the G238S mutant is much fitter than
any other mutation, and we reran the analysis without this mutant
(Figure S4). Although ke is lower without G238S it is still in the
Fre´chet domain. Finally, we also estimated k while including only
the non-synonymous mutations in the mature protein for analysis,
and again confirmed the rejection of Gumbel in favor of the
Fre´chet domain (Figure S5). The number of synonymous
mutations was too low to perform a similar analysis of this subset.
Distribution of fitness effects
The fraction of cells that grow into a visible colony (Psur) at each
Ctx concentration (used to estimate IC99.99) can also be used to
estimate the fitness effects of the 48 beneficial mutants in the
presence of Ctx. By simulating reproduction and survival as a
branching process, we can estimate the probability that an
individual cell survives onto the next generation (p) from Psur (see
Material and Methods). When the cell survives into the next
generation it will divide and the expected number of offspring is
2p, which is equivalent to the Wrightian fitness W. The selection
coefficient s is then calculated by Wi/W0–1, where Wi and W0 are
the fitness of mutant and wild type, respectively. Because we
Figure 1. Survival of E. coli cells and distribution of the minimum inhibitory concentrations of Ctx. (A) Survival of E. coli cells with
plasmid-borne TEM b-lactamase at various Ctx concentrations. Ctx concentrations are plotted on a log2 scale. Survival is plotted as the fraction of
surviving cells (6 S.D.) on a log10 scale. Comparison between cells carrying pACTEM1 plasmids and plasmids from the libraries generated by error-
prone PCR. On average, 0.6 errors were introduced per amplicon. (B) Distribution of the Minimum inhibitory concentrations (MIC) of Ctx for isolates
with a unique beneficial mutation in TEM (n= 48), and the corrected distribution which takes into account the estimated total number of beneficial
mutations (n=87; see Table 1). Ctx concentrations are plotted on a log2 scale.
doi:10.1371/journal.pgen.1002783.g001
Fitness Effects of Beneficial Mutations
PLoS Genetics | www.plosgenetics.org 3 June 2012 | Volume 8 | Issue 6 | e1002783
assume no effects of the antibiotic on the birth rate (generation
time), W has an upper bound of 2, and the selection coefficient is
restricted to values between 0 and 1.
In principle, we can only determine selection coefficients under
conditions that allow some survival of the wild type (i.e. up to
0.08 mg Ctx/mL). In order to extend our analyses to higher
concentrations, we instead calculate selection coefficients with
respect to the least fit beneficial mutant at 0.02, 0.04, 0.08 and
0.16 mg Ctx/mL. The estimates of k for the distribution of
selection coefficients (Figure 4A) suggest that the shape of the
distribution depends on the Ctx concentration: at 0.02 mg/mL, ke
is negative, suggesting a truncated tail (Weibull domain) –
although it cannot be distinguished statistically from 0 (Gumbel
domain), while at concentrations of 0.04 mg/mL and higher ke is
significantly positive, suggesting a heavy tail (Fre´chet domain;
Figure 4B and 4C). Our interpretation of these results is that at low
Ctx concentration, the DBFE is affected by the upper limit of 1 set
for s, and only at higher Ctx concentrations it can reveal its
unconstrained shape. Since other studies have used Psur itself as
proxy for fitness, we have also looked at its distribution (Figure S6),
more precisely at the DBFE corresponding to ssur~Psur=P
(1)
sur{1,
where P(1)sur is the observation probability of the least fit beneficial
mutant observed. This estimator yields very large selection
coefficients, but also supports Fre´chet for Ctx concentrations
higher than 0.04 mg/mL.
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Figure 2. Number of observed beneficial mutations per codon
and the effect sizes of the beneficial replacements. (A) Number
of observed beneficial mutations per codon. Note that the numbering is
based on the consensus sequence of class A b-lactamase and that
codons 1, 2, 239 and 253 are not present in TEM. Green bars represent
synonymous mutations and blue bars non-synonymous mutations. (B)
The effect sizes of the beneficial replacements are mapped onto the
crystal structure of TEM-1. Colours indicate the increase in Ctx resistance
relative to TEM-1 caused by the mutation with the largest effect size at
each position. The insert shows the same structure rotated horizontally
by 180u.
doi:10.1371/journal.pgen.1002783.g002
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Discussion
We studied the adaptive potential of the enzyme TEM-1 b-
lactamase in a novel environment. We generated random
mutations, estimated the total number of beneficial mutations
and determined the distribution of their effects on Ctx resistance
and fitness. We characterized 48 beneficial mutations and our
statistical analyses suggest that at least 3.4% of all mutations are
beneficial under the experimental conditions, a substantial fraction
of which are synonymous mutations. We also found that the
distribution of resistance and fitness effects of these mutations
belongs to the Fre´chet domain of heavy-tailed distributions.
Although the adaptive potential that we estimate for TEM-1 b-
lactamase is high, the real number of beneficial mutations is likely
to be even higher, because our estimates are conservative. Other
recent studies have also found frequencies of beneficial mutations
in the order of 1–10% [3,12,24,29,30]. One should take into
account that TEM is a known target for Ctx resistance [2,26,27]
and already has promiscuous activity towards this antibiotic, which
is an important prerequisite for successful directed evolution [31].
During the process of directed evolution, iterative rounds of
mutagenesis and artificial selection are performed. The difference
with our study is mainly that we are interested in characterizing
the full adaptive potential of the enzyme, including beneficial
mutations with small effect, whereas directed evolution studies are
biased towards finding large-effect mutations, as well as functional
combinations of mutations. As a consequence, 18 of the 38 non-
synonymous mutations that we identified are new, including
mutations with large effect (see Table S2). Protocols for directed
evolution sometimes allow the simultaneous selection of multiple
mutations. These protocols have been applied to TEM as well
[2,26,27], but it is then unclear whether the identified mutations
are beneficial in the wild-type background or only when particular
other mutations are present. With each fixation the mutational
neighborhood changes, thereby granting access to mutations that
are inaccessible for the original background [32] and obstructing
access to others due to sign epistatic interactions [2,4]. This is for
example true for compensatory mutations such as M182T and
T265M, which restore stability to enzymes that have become
unstable as a result of mutations that increased activity [33–35],
but are not beneficial in the stable wild-type background.
Although epistasis affects the identity of mutations which are
beneficial with each change in the genetic background, the DBFE
may be unaffected [36]. This is an important topic for future
investigation.
Beneficial mutations that increase Ctx resistance either increase
the concentration of correctly folded enzyme or the activity per
molecule, and may affect both aspects in opposite ways [35,37].
Mutations in the signal peptide and synonymous mutations will
likely increase enzyme levels. For example, mutation Q6R is
known to increase periplasmic expression levels of TEM [38].
Synonymous mutations may prolong mRNA half-life [39],
facilitate correct folding and export of the protein [40], or affect
mRNA stability and translation [41]. Interestingly, Lind et al. [42]
showed that the distribution of fitness effect of deleterious
mutations in ribosomal proteins did not differ for synonymous
and non-synonymous mutations, while Lalic et al. [30] also
identified multiple synonymous mutations among mutations that
expanded the host range for a plant virus. We found that the shape
of the distribution did not change significantly when excluding
synonymous mutations, while synonymous mutations had on
Figure 3. Distribution and likelihood analysis. (A) Distribution of
Ctx resistance levels (IC99.99) of 48 beneficial mutants. (B) Likelihood
analysis of the estimated shape parameter (ke). ke is plotted against the
number of beneficial mutants (ranked by their effect) that were
included for the estimation (n) by using a fitness threshold (wc). Because
each value of n corresponds to a range of values for wc, there is also a
range of ke associated with every n. The dashed line corresponds to
k= 0. ke is well above zero in the whole depicted range, suggesting that
the distribution belongs to the Fre´chet domain. (C) The P-value
corresponding to the hypothesis k= 0 is plotted against n. For all
choices of wc and n.14 the null hypothesis can be rejected with more
than 95% confidence as indicated by the dashed line.
doi:10.1371/journal.pgen.1002783.g003
Figure 4. Distribution of the selection coefficients, likelihood
analysis, and P-value. (A) Distribution of the selection coefficients (s)
of the 48 beneficial mutations for four low Ctx concentrations as
inferred from survival data using a branching model. Vertical dashed
lines show the boundaries between the logarithmic bins used in the
analysis. The distribution shifts towards smaller values of s as the
antibiotic concentration increases, while a group of very fit mutants
persists near the maximum selection coefficient s= 1. (B) Likelihood
analysis of the estimated shape parameter (ke) for the four distributions.
The ML estimate ke is plotted against the number of beneficial mutants
that were included for estimation (n) by using a fitness threshold (wc).
Because each value of n corresponds to a range of values for wc, there is
also a range of ke associated with every n. (C) The P-value
corresponding to the hypothesis k= 0 is plotted against n. The null
hypothesis can be rejected with more than 95% confidence for data
points beneath the dashed line. All panels correspond to Nlim = 100,000
bacteria and Texp = 40 generations. See Figure S7 for a similar analysis,
where Texp = 40 generations and Nlim = 1,024 bacteria.
doi:10.1371/journal.pgen.1002783.g004
Fitness Effects of Beneficial Mutations
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average a lower effect on Ctx resistance than non-synonymous
mutations. Vakulenko et al. [43] showed that poor activity of
TEM-1 is caused by steric hindrance due to the bulky side-groups
of modern cephalosporins such as Ctx. The majority of the
identified replacements were located in close vicinity to the
catalytic site in the oxyanion cavity or on loops near the entrance
of this cavity (Figure 2B). This suggests that they either have a
specific interaction with the Ctx substrate or enlarge the cavity, as
has been suggested for the mutations R164S and G238S [2,43,44].
We presented a novel procedure to infer fitness from the
survival of bacterial cells at various Ctx concentrations. Previous
studies made attempts to estimate fitness benefits of antibiotic
resistance mutations using competition assays or growth rate
measurements [10,45,46], but these measurements typically
involve substantial efforts and large measurement errors (but cf.
[42]). We quantified the probability that a single cell produces a
visible bacterial colony by simulating reproduction and survival
per cell generation as a branching process. The advantage of this
procedure is that each surviving colony contributes to an aggregate
estimate of the survival probability per cell generation. A potential
limitation of the current approach is the assumption that fitness is
only affected by differences in survival and not by differences in
birth rate (i.e. generation time). Our assumption is supported by
Negri et al. [45], who observed that initial growth rates did not
differ between different mutants of TEM. Nevertheless, it will be
interesting to compare the fitness estimates yielded by our method
to estimates from other methods, such as direct competitions, and
to confirm the assumption underlying our procedure.
The results of our study combined with previous studies on the
shape of the DBFE suggest that the DBFE cannot be generally
described by an exponential distribution. Instead, its shape will
vary among organisms and environments. Examples are now
known for all universality domains (Gumbel, Weibull and Fre´chet).
Most studies have encountered an exponential DBFE [9–11], two
studies have observed distributions with truncated tails [15,16],
while our study is the first to find that the effects of beneficial
mutations follow a distribution that belongs to the Fre´chet domain.
Lalic et al. [30] recently reported a DBFE for an RNA plant virus
that was best fitted by a Pareto distribution, a member of the
Fre´chet EVT class. However, their distribution was based on the
effects of 20 random mutations and may have included deleterious
ones, while their inferred estimate of shape parameter k was very
small (k<0.045), making it unlikely that the Gumbel domain could
be rejected with statistical confidence. Also in our case, the shape
of the distribution depends on environmental conditions: we
observed heavy tailed distributions at high Ctx concentrations, but
found a truncated or exponential tail at the lowest Ctx
concentration where wild-type fitness was high. MacLean and
Buckling [10] also found the DBFE to depend on the wild-type
fitness. They tested the DBFE of 15 beneficial mutants in rpoB at
various rifampicin concentrations and could reject the exponential
null hypothesis at high concentrations. However, they did not
estimate the shape parameter k of the GPD.
An organizing principle that may help explain the variation in
observed DBFEs is the variation in pleiotropic constraints
associated with the beneficial mutations studied. Mutations that
increase resistance to an antibiotic also incur fitness costs due to
pleiotropic effects on other cellular functions, which often make
their benefit conditional on the presence of the antibiotic [47]. The
enzyme we chose for our study may be atypical in this respect,
since the only catalytic activity of b-lactamases involves the
hydrolysis of b-lactams [48], while resistance to other antibiotics is
often caused by changing structural or metabolic components that
are targeted by the antibiotic [47]. It is conceivable that the
pleiotropic constraints experienced during adaptation of a
specialized enzyme are different from those involved in adapting
a component with an existing function, although it is less clear in
what respect. Limited pleiotropic constraints are consistent with
the presence of a few exceptionally fit mutants in our system and
the support we found for a Fre´chet-type distribution. However, it
may be naı¨ve to think that pleiotropic constraints are smaller for
our enzyme, because both internal constraints from counteracting
effects on enzyme activity and stability, and external constraints
through negative effects from high concentrations of periplasmic
enzymes interfering with nutrient uptake and from protein
aggregates and the associated recruitment of limiting chaperones
may occur [35,37].
Our observation that beneficial mutations follow a Fre´chet
distribution has implications for the repeatability and dynamics of
adaptation, in particular in the context of antibiotic resistance
[47]. Fre´chet distributions are characterized by many small-effect
mutations and a ‘‘heavy tail’’ with a few mutations with
exceptionally large effects. The existence of these latter mutations
increases the short-term probability of parallel evolution, which
can be quantified by the probability P2(n) that two replicate
populations fix the same mutation out of n available beneficial
mutations. When the DBFE is in the Gumbel domain, P2(n) = 2/
(n+1), which is about twice the neutral value [20]. With a moderate
departure from the Gumbel into the Fre´chet domain, P2(n) is still
proportional to 1/n, but with a coefficient that increases with
increasing k and diverges at k=K, where the distribution ceases
to have a finite second moment [14]. ForK,k,1, the probability
of parallel evolution decreases more slowly with the number of
neighboring genotypes as 1/n2(1/k21) [J. Krug, unpublished],
while adaptation becomes even more deterministic for k.1, when
P2(n) approaches a nonzero constant P2 = 121/k for large n [J.
Krug, unpublished; [49]]. Similarly, the probability Pmax that the
mutation of largest effect is fixed approaches a constant value that
is bounded from below by P2 [J. Krug, unpublished; [49]]. To
illustrate this, the estimates of P2 and Pmax were derived from the
experimentally determined selection coefficients. Both measures of
repeatability increase monotonically with increasing Ctx concen-
tration, and for concentrations above 0.04 mg Ctx/mL repeat-
ability is much greater than predicted for the Gumbel class (Table
S3 and Figure S8). These results are, at least qualitatively,
consistent with a recent observation that 10 of the 12 replicate
lines of TEM-1 b-lactamase adapting to Ctx substituted G238S,
the largest-effect mutation of our set of 48, as the first mutation
[2], as well as with a report of remarkable parallel evolution
towards trimethoprim resistance [1].
The shape of the DBFE also affects the length of adaptive walks.
Assuming a maximally rugged, uncorrelated fitness landscape,
recent theoretical studies have shown that the average number of
adaptive steps required to reach a local fitness maximum increases
logarithmically with initial fitness rank when k,1, but becomes
independent of this quantity when k.1 [17–19]. In the extreme
Fre´chet domain (k.1), the mutation of highest fitness is
overwhelmingly likely to be fixed in each step, so the walk
effectively becomes ‘greedy’ and typically terminates after a small
number of substitutions [21]. A heavy-tailed DBFE thus provides a
possible explanation that could account for the short adaptive
walks observed in recent experiments [50,51]. Finally, the very fit
mutants that are in the broad tail of the distribution can swiftly
sweep to fixation and outcompete mutants with smaller effect. This
mitigates the effects of competition among beneficial mutations
(clonal interference), and particularly decreases the probability
that multiple beneficial mutations accumulate on the same genetic
background during a selective sweep [3,22,23]. Given these
Fitness Effects of Beneficial Mutations
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diverse and fundamental consequences, it is imperative to
understand the conditions that yield Fre´chet-type DBFEs.
Materials and Methods
Bacterial strain and plasmids
Escherichia coli strain DH5aE was used as the host for all
plasmids. TEM-1 was amplified from pBR322 and cloned into the
pACSE3 plasmid to yield pACTEM1 [26]. This plasmid carries a
tetracycline resistance gene; we added 15 mg tetracycline/mL in
all cultures to ensure its preservation. Cultures were grown at
37uC. Expression of TEM alleles is controlled by the pTac
promoter that is in turn regulated by the lac repressor which is
encoded by the lacI gene on pACSE3. Expression of TEM alleles
was induced by adding 50 mM isopropyl-b-D-thiogalactopyrano-
side (IPTG) [26].
Mutagenesis
We introduced random mutations into TEM-1 using the
GeneMorph II random mutagenesis kit (Stratagene) and the
primers P3 (TCATCCGGCTCGTATAATGTGTGGA) and P4
(ACTCTCTTCCGGGCGCTATCAT), which flank the multiple
cloning site of pACSE3. The mutagenesis conditions were
modified to induce ,0.6 mutations per amplicon by using
100 ng of template and replacing one twentieth of Mutazyme II
polymerase by Pfu polymerase (Stratagene). The cycling program
consisted of: denaturation at 95uC for 2 min, 30 cycles of
denaturation (30 sec at 95uC), annealing (30 sec at 60uC), and
extension (75 sec at 72uC), followed by a final step at 72uC for
10 min. Substitutions that arise early during the PCR reaction
dominate the final mixture due to the branching nature of the
amplification process [52]. To increase the diversity of mutations,
we carried out twelve independent PCRs.
The immediate mutational neighborhood (i.e. Hamming
distance = 1) of TEM-1 contains 2,583 point mutants (excluding
insertions and deletions). Given the average observed mutational
load of ,0.6 errors per sequence (based on sequencing 24 non-
selected transformants) and ,106 transformed cells per library,
one expects that all 2,583 one-step mutants are present in the
transformation mixture at least once (http://guinevere.otago.ac.
nz/cgi-bin/aef/pedel.pl, [53]), but that a significant fraction of the
amplicons contains no or multiple mutations.
Isolation of mutants with increased Ctx resistance
Amplicons were purified using the GenElute PCR Clean-Up
Kit (Sigma-Aldrich) according to the manufacturer’s instructions.
Amplicons were digested with BspHI and SacI restriction enzymes
(New England Biolabs), purified, ligated into pACSE3 using T4
DNA ligase (New England Biolabs), and then electroporated into
DH5aE. The original pACTEM1 plasmid was also electroporated
into DH5aE. Cells were allowed to recover in SOC medium (20 g
tryptone and 5 g yeast extract/liter supplied with 10 mM NaCl,
2.5 mM KCl, 10 mM MgSO4, 10 mM MgCl2, and 20 mM
glucose) for 60 minutes.
To select mutants with increased resistance to Ctx (Sigma-
Aldrich) relative to TEM-1, we first determined at which Ctx
concentration pACTEM1 (n= 4) and the mutated libraries (n= 12)
produce viable colonies. Directly after recovery, three aliquots
from each transformation mixture were spread onto LB agar
plates without Ctx - to determine the number of transformants per
library - and onto LB agar plates with a two-fold increase of Ctx
concentrations ranging from 0.01 to 0.64 mg/mL. Plates were
incubated (40 h) and colony counts revealed the library size and
the surviving fraction at each Ctx concentration. The lowest
concentration at which pACTEM1 clearly displayed reduced
survival was 0.04 mg Ctx/mL (Figure 1). For all 12 libraries, we
subsequently picked a random sample of 72 colonies from plates
with 0.04 mg Ctx/mL. This adds up to a total of 864 clones, which
were grown overnight (O/N) in microtiter plates with LB medium.
Ten-% glycerol stocks of all isolates were stored at 280uC.
Pre-screening by MIC assay
To determine which Ctx resistance classes were present among
the isolates we first screened all isolates by measuring the
minimum inhibitory concentration (MIC) using the broth dilution
method. Before screening, cultures were revived by diluting them
1:100 in LB medium with tetracycline and grown O/N. Cultures
were then rediluted at a titer of ,105 cells/mL into fresh LB
medium in a series of microtiter plates with a two-fold increase in
Ctx concentrations ranging from 0.01 to 2.56 mg/mL. Cultures
were incubated and the MIC was established as the lowest Ctx
concentration that gave no visible growth. Note that spontaneous
mutations outside the TEM-1 gene may have occurred during the
selection procedure. These were not excluded before the MIC
assay, and may partly explain the presence of survivors with the
wild-type allele at high Ctx concentrations.
Sequencing and mapping of mutations
To identify mutations in TEM, we amplified this gene using Pfu
polymerase and the primer pair P3–P4. PCR products were
sequenced using the BigDye sequencing kit. To obtain a balanced
sample, we divided all isolates into six classes according to their
MIC (0.08, 0.16, 0.32, 0.64, 1.28 and $2.56 mg Ctx/mL). We
continued sequencing until we identified 36 sequences with a
single substitution in each MIC class, balanced across the 12
replicate PCR reactions. Double mutants and wild-type (TEM-1)
sequences were discarded from further study. In addition, we
sequenced ten colonies from the pACTEM1 libraries which
survived on the plates with 0.08 mg Ctx/mL to examine the
presence of spontaneous mutations in TEM-1, which were not
present. Sequences were analyzed using MEGA software. Muta-
tions were numbered according to Ambler et al. [54]. Amino acids
replacements were mapped onto the crystal structure of TEM-1 in
PyMOL [55] using the coordinates of the wild-type structure
(Protein Data Bank ID: 1ZG4).
Resistance assay
Ctx resistance levels of all unique mutants were estimated by
determining survival on agar plates in the presence of Ctx. To
exclude spontaneous mutations in the E. coli background or the
plasmid (outside TEM), we ligated the sequenced PCR products
back into pACSE3 and electroporated the plasmids into a new
batch of DH5aE. For each mutant, two to four replicate cultures
were plated at the appropriate dilutions onto a series of LB agar
plates with two-fold increases in Ctx concentrations ranging from
0.01 to 5.12 mg/mL. After 40 h of incubation, colony counts were
compared to the effective library size to determine the fraction of
cells that produced a visible colony at each Ctx concentration. The
resistance level (IC99.99) was defined as the Ctx concentration at
which a fraction 1024 of the cells produces a visible colony. This
value was calculated by linear interpolation from the two adjacent
data points. The threshold of 1024 cells was chosen based on the
abundant occurrence of chromosomal resistance mutations in
OmpF, which are known to occur at a frequency of 1025 [45,56].
The MIC and IC99.99 values of the 52 isolated mutants with a
single mutation were a strongly correlated (r= 0.90, n = 50,
P,0.001).
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Statistical procedures
We estimated how many mutants have been overlooked in our
isolation procedure by adapting the procedure described in [57].
When all mutants have equal observation probabilities, the
probability to observe n unique mutants from a total of N existing
mutants in k picks, PN [Xk = n], can be calculated analytically.
Since k and n are obtained from the experiments, one can calculate
the most likely value of N by means of a maximum likelihood (ML)
analysis by demanding PN [Xk = n] to be maximal at the most likely
N, NML. The associated 95% confidence interval is obtained by
calculating the values of Nci for which the sum over the
probabilities
PNci
N~n
PN Xk~n½ =
P?
N~n
PN Xk~n½  is smaller or larger
than 0.025 and 0.975, respectively. Given the potential differences
in detection probability between large and small-effect mutations,
we ran a separate analysis for the six MIC classes. By assuming
equal observation probabilities for all mutants within a MIC class
and by isolating three transformants per MIC category from the
same library, we may introduce a systematic error that increases
the number of identical mutants; therefore, our estimate of the
total number of mutants is conservative.
We tested whether the 52 unique mutants had a significantly
higher resistance phenotype (IC99.99) than TEM-1 using two-
sample two-tailed t-tests. This leaves the possibility open for
mutants that are less resistant than TEM-1, of which we found
four (Table S2). Since the variance and mean of our IC99.99
estimates were strongly positively correlated (r= 0.904), all t-tests
and regressions were performed using log(IC99.99), which
homogenized the variance and removed the positive correlation
(r=20.030).
Generalized Pareto distribution
To assign the shape of the DBFE to a domain of extreme value
distributions, we fitted a generalized Pareto distribution (GPD) to
the obtained data, using a maximum likelihood (ML) procedure,
essentially following the procedure in [58]. The GPD is
characterized by a scale parameter t and a shape parameter k.
The fit yields an estimate for k (ke), whose value attributes the
distribution to one of three universality domains [59]. The GPD is
given by:
f (x k,tj )~
1
t
(1z
kx
t
){((kz1)=k), x§0, if kw0, Frechetð Þ
1
t
(1z
kx
t
){((kz1)=k), 0ƒxv{ tk , if kv0, Weibull domainð Þ
1
t
e{x=t, x§0, if k~0, Gumbel domainð Þ
8>>><
>>>:
The GPD describes the limiting tail behavior, which is expected to
be visible above a certain threshold (wc). If the data correspond to
the tail of some distribution, sliding the threshold shifts the scale
parameter by t?tzwck, but leaves the estimate for k unaffected.
Although the wild-type fitness seems a ‘‘natural’’ threshold, a
higher threshold is sometimes preferable. For example, Beisel et al.
[58] proposed to use the fitness of the beneficial mutant with the
smallest effect as wc. This was done to remove the error that arises
from overlooking small-effect mutations and to allow the analysis
of gain-of-function mutations. Threshold selection is a standing
problem for this type of analysis and different approaches exist (see
[60,61]). In the present context, a key concern is that the
probability of overlooking mutations depends on the effect-size.
We tackled this problem by estimating k for various choices of wc.
One should then obtain a range of wc values in which ke is stable.
If this is not the case, we are probably not observing the tail of a
distribution in the sense of extreme value theory.
A likelihood ratio test is performed to assess whether the
null hypothesis k= 0 (Gumbel domain) [7] can be ruled
out. Following the procedure in [58], we first calculated
{2 ln Lð Þ~2 ‘ X Dke,teð Þ{‘ X D0,t0e
  
, where ‘(X Dke,te) is the
log-likelihood of the measured fitness values given ke and te, and
‘(X D0,t0e) is the log-likelihood for estimating value t
0
e under the
hypothesis that k= 0. Next, we produced 1000 datasets for each
value of wc by numerically picking random numbers from a GPD
with parameters k= 0 and t~t0e . The fraction of cases for which
2ln(L) is larger for the experimental data than for the numerically
obtained data gives the P-value corresponding to the hypothesis
k= 0. We checked to what extent measurement error altered our
estimates. In that case, the likelihood (L) is calculated by taking
products of the convolutions of the probability density function
with Gaussians representing the uncertainty in the measurement of
the fitness values (see [58]): L(w1,w2, . . . ,wn,s1,s2, . . . ,snDk,t)~
Pni~1
Ð
f (xDk,t)g(wi Dx,si)dx, where n is the number of considered
mutants, f is the GPD, and g is a Gaussian with mean wi and
variance si. The values of wi and si are extracted from the
replicated measurements of the IC99.99 or fitness. As the estimates
for k and t change very little when taking into account
measurement error, we only present data for the unperturbed
cases.
Survival probability as a fitness measure
By modeling reproduction and survival as a branching process,
we established a relation between survival in the presence of the
antibiotic and fitness. Suppose that subsequent generations of
individuals in a population reproduce (double) themselves with
probability p or die with probability (12p). The expected number
of offspring is then 2p, which can be identified as the Wrightian
fitness W. In order to be visible, a colony of bacteria has to reach a
minimal size, Nlim<100,000 bacteria in the time span the
experiment is carried out, Texp<40 generations. The probability
that this happens is the measured survival probability Psur. In order
to be able to infer the value p, and thus W, from the measured Psur,
we simulated the branching process for 1000 values of p,
equidistantly distributed between 0 and 1, and measured the
fraction of runs in which Nlim was reached in 40 or less
generations, f(p). If our model is correct, Psur = f(p) and therefore
p= f21(Psur). We calculated p by backtracking for which value the
measured Psur would be expected. Missing values of f(p) were
obtained by linearly interpolating its logarithm. We then
calculated the selection coefficient of the mutants with respect to
the least fit beneficial mutant observed (W1), s=W/W121. Note
that calculating s with respect to the wild-type fitness instead does
not change the estimates considerably, but would not allow us to
use the data corresponding to 0.16 mg Ctx/mL. We verified that
our measurements do not depend too strongly on the particular
choice of Nlim (see Figure S7).
By construction, s can only take values between 0 and 1 due to
the restriction 2$2p.1. At a first glance, it appears as if the sharp
upper cutoff for s will inevitably force the distribution towards the
Weibull domain. However, at 0.04, 0.08, and 0.16 mg Ctx/mL,
where nearly all mutants have strongly reduced survival proba-
bilities, the upper bound is not relevant and other classes of
distributions are possible. At 0.02 mg Ctx/mL the recovered
distribution is in the Weibull domain (albeit not significantly
different from Gumbel), but note that here the DBFE may be
affected by the upper limit for s of 1.
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By means of the selection coefficients we further calculate the
probabilities of parallel evolution, P2~
P
i (si=
P
j sj)
2
, and the
probability for the fittest mutant to take over the population,
Pmax~smax=
P
i si, where smax is the selection coefficient corre-
sponding to the fittest mutant and the sums in the expressions run
over all beneficial mutations [20]. Note that both measures
correspond to the strong selection weak mutation regime and are
obtained using Haldane’s expression for the fixation probability,
p= 2s, which presumes 2s«1 [62]. For larger values of s, the
expressions would need to be modified, but the overall tendency of
increasing P2 and Pmax for increasing k values is maintained.
Supporting Information
Figure S1 Histogram displaying the relative frequencies of MIC
values of E. coli cells with plasmid-borne TEM b-lactamase that
carry (1) the wild-type TEM-1 allele, (2) alleles from the mutated
libraries that survived exposure to 0.04 mg Ctx/mL on plates
(n= 864), and (3) alleles from the mutated libraries that carry only
a single mutation (based on sequencing a sample of 310 isolates).
MIC values were determined without transformation into a fresh
isogenic background, and the potential presence of mutations
outside the TEM gene was not eliminated in this assay. Note that
Ctx concentrations are plotted on a log2 scale.
(TIF)
Figure S2 Survival of E. coli cells with plasmid-borne TEM b-
lactamase at various Ctx concentrations. Survival is plotted as the
fraction of surviving cells (6 S.D.) on a logarithmic scale, and Ctx
concentrations are plotted on a log2 scale. Comparison between
cells carrying pACTEM1 and three mutants with a large (G238S),
intermediate (E104K) and small-effect beneficial mutation
(I173V), which shows the range of resistance effects encountered
in this study.
(TIF)
Figure S3 Likelihood analysis of the estimated shape parameter
(ke) of the GPD. In the upper panel, ke is plotted against the
number of beneficial mutants, ranked by their effect on resistance,
that were used for the estimation (n) by using a threshold (wc). The
IC99.99 was calculated as the Ctx concentration at which a
fraction of 1024 cells survived. This figure displays ke correspond-
ing to fractions of 1022, 1023, and 1025 surviving cells to calculate
the inhibitory Ctx concentration. Note that every n corresponds to
a range of values of wc and thus to a range of estimates for ke. The
dashed line corresponds to k=0. ke exceeds 0 for 15#n#50. The
P-value corresponding to the hypothesis k=0 is plotted against n
in the lower panel. The dashed line corresponds to the 95%
confidence level. The hypothesis can be rejected with more than
95% confidence for all choices of wc and 15#n#48.
(TIF)
Figure S4 Analogous to Figure S3. The results of the likelihood
analysis without the fittest mutant (G238S) are shown. This
mutant is excluded to determine whether the condition k.0 does
not solely depend on this mutation. Compared to Figure S3, ke
shifts towards smaller values, but remains positive. The P-values
obtained for the hypothesis k=0 are generally larger compared to
the analysis with G238S, but remain below 0.05 (shown by the
dashed line) for 30#n#45.
(TIF)
Figure S5 Analogous to Figure S3. The results of the likelihood
analysis for only the non-synonymous mutations in the mature
protein (n= 35) are shown. The removal of synonymous mutations
does not affect the shape of the distribution.
(TIF)
Figure S6 (A) Fractions of isolates are plotted versus the
logarithm of the selection coefficient (as inferred from survival
data) for four low Ctx concentrations. Vertical dashed lines show
the boundaries between the logarithmic bins used in the analysis.
(B) Likelihood analysis of the estimated shape parameter (ke) for
the distribution of selection coefficients. The ML estimate ke is
plotted against the number of ranked beneficial mutants that were
included for estimation (n) by using a fitness threshold (wc). Because
each value of n corresponds to a range of values for wc, there is also
a range of ke associated with every n. (C) The P-value
corresponding to the hypothesis k= 0 is plotted against n. This
hypothesis can be rejected with more than 95% confidence for
data points beneath the dashed line.
(TIF)
Figure S7 Analogous to Figure 4, but for Nlim = 1,024 bacteria
and Texp = 40 generations. (A) Fractions of isolates are plotted
versus the logarithm of the selection coefficient (as inferred from
the branching process) for four low antibiotic concentrations.
Vertical dashed lines show the boundaries between the logarithmic
bins used in the analysis. The distribution shifts towards smaller
values as the antibiotic concentration increases, while a group of
very fit mutants persists near the maximum selection coefficient
s= 1. (B) Likelihood analysis of the estimated shape parameter (ke)
for the distribution of selection coefficients. The ML estimate ke is
plotted against the number of beneficial mutants (ranked by their
fitness effect) that were included for estimation (n) by using a fitness
threshold (wc). Because each value of n corresponds to a range of
values for wc, there is also a range of ke associated with every n. (C)
The P-value corresponding to the hypothesis k= 0 is plotted
against n. This hypothesis can be rejected with more than 95%
confidence for data points beneath the dashed line.
(TIF)
Figure S8 The probability of parallel evolution (P2) and the
fixation probability of the fittest mutant (Pmax) as inferred from the
selection coefficients, are plotted versus antibiotic concentration.
We also plot the prediction for the probability of parallel evolution
in the case of a Gumbel class distribution, PGumbel2 ~
2
Nz1
, where N
is the number of beneficial mutants [20]. Note that, unlike the
Gumbel case, we predict an increase in the frequency of parallel
evolution events with increasing antibiotic concentration.
(TIF)
Table S1 Mutation spectrum of the Mutazyme system. Muta-
tion spectrum of the Mutazyme system used for PCR mutagenesis
in our experiments. Sequenced isolates were recovered from an
unselected library (0.00 mg Ctx/mL).
(DOCX)
Table S2 Identified unique mutations in TEM-1 b-lactamase
ranked by their Ctx resistance. The table lists whether the adaptive
mutations have previously been identified in clinical isolates
(according to http://www.lahey.org/studies/ temtable.asp; ver-
sion 17 November 2011) or in laboratory experiments (according
to [25]). The table also indicates how often a mutation has been
sampled and in which MIC category it has been identified. Note
that the listed frequencies refer to MIC measurements of different
independent isolates and a particular genotype can consequently
be identified in multiple MIC categories. MICs were determined
directly after isolation, while IC99.99 levels were established after
transformation into an isogenic background. Improvement is
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calculated by dividing the IC99.99 of the mutants by the IC99.99
of pACTEM1.
(DOCX)
Table S3 Probability of parallel evolution (P2) and fixation of
largest-effect mutation (Pmax). Estimates are obtained from
selection coefficients at various antibiotic concentrations.
(DOCX)
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